Novel Clickable Alkyne-Terminated Sulfonamide Cyclodextrins with Extended Hydrophobic Cavity

Background

Cyclodextrins are cyclic oligosaccharides widely used in pharmaceuticals, food, and environmental applications due to their ability to form inclusion complexes with various molecules. They enhance the solubility, stability, and bioavailability of hydrophobic compounds, making them invaluable in drug delivery systems and molecular recognition processes. However, the native cyclodextrins often suffer from limited solubility and binding specificity, restricting their effectiveness in complex applications. There is a growing demand for modified cyclodextrins that offer greater water solubility and tailored binding capabilities to accommodate a broader range of target molecules and improve performance in specialized settings.

Current synthetic approaches to modifying cyclodextrins face several challenges that hinder the development of advanced functional derivatives. Traditional methods often involve multiple reaction steps with low yields and significant side product formation, leading to inefficiencies and increased production costs. Additionally, achieving precise control over the degree of substitution and functional group placement is difficult, resulting in heterogeneous products with inconsistent properties. Purification processes are typically complex and time-consuming, further complicating the synthesis of high-purity modified cyclodextrins. These limitations restrict the versatility and scalability of current methods, making it challenging to produce tailored cyclodextrin derivatives necessary for innovative applications in fields such as targeted drug delivery and complex molecular sensing.

Technology

The technology presents a novel synthesis method for single isomer alkyne-modified sulfonamide cyclodextrins, specifically targeting heptakis-2,3-β-dimethyl-6-β-sulfobutyl-β-cyclodextrin. The process involves four main stages: forming a sulfonyl chloride cyclodextrin by reacting per-6-substituted sulfoalkyl cyclodextrin with cyanuric chloride, introducing alkyne functionality through reaction with propargyl amine, performing a copper-catalyzed azide-alkyne cycloaddition to attach polyethylene glycol (PEG) chains, and characterizing the final PEGylated product using various NMR techniques. This method is versatile, allowing application to different cyclodextrin types (α and γ) and enabling variations in substitution and side-chain modifications to produce a wide range of structural derivatives with enhanced water solubility and binding capabilities.

What sets this technology apart is the structural modification that extends the hydrophobic cavity of the cyclodextrins through sulfobutyl ether arms and methyl ether groups, thereby improving their capacity to bind hydrophobic molecules. Additionally, the incorporation of the triazole linkage on a flexible arm positioned away from the cyclodextrin ring distinguishes these PEG-triazole-sulfonamide-β-CDs from other click-modified cyclodextrins. The method’s efficiency is demonstrated by high-yield reactions that require minimal purification, and the flexibility in controlling substitution degrees and PEGylation allows for the tailored creation of diverse cyclodextrin derivatives. This makes the synthesis approach highly valuable for applications in drug delivery, molecular recognition, and other areas requiring customized cyclodextrin-based systems.

Benefits

• Enhanced water solubility and binding capabilities of cyclodextrins
• Versatile synthesis applicable to multiple cyclodextrin types (α, β, γ)
• High reaction efficiency with minimal side-products
• Flexible substitution and PEGylation for tailored applications
• Ability to create diverse derivatives for drug delivery and molecular recognition

Applications

• Drug Delivery Systems
• Molecular Sensors
• Pharmaceutical Formulations
• Environmental Remediation Agents
• Cosmetic Ingredient Delivery

Additional info

A novel synthesis method produces single isomer alkyne-modified sulfonamide cyclodextrins, specifically heptakis-2,3-β-dimethyl-6-β-sulfobutyl-β-CD. The four-stage process includes sulfonyl chloride formation, alkyne functionalization with propargyl amine, copper-catalyzed azide-alkyne cycloaddition using azide-PEGs, and NMR-based characterization and purification. This approach enables water-soluble PEG-triazole-sulfonamide-β-CDs with enhanced binding, applicable to α and γ cyclodextrins for diverse substitution and side-chain modifications, suitable for drug delivery and molecular recognition applications.